ABC | Volume 112, Nº2, Fevereiro 2019

Artigo de Revisão Fontes-Carvalho et al O ano de 2018 em cardiologia: ABC cardiol e RPC em resumo Arq Bras Cardiol. 2019; 112(2):193-200 Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 26. Silva CG, Klein CH, Godoy PH, Salis LH, Silva NA. Up to 15-year survival of men and women after percutaneous coronary intervention paid by the brazilian public healthcare system in the state of Rio de Janeiro, 1999-2010. Arq Bras Cardiol. 2018;111(4):553-61. 27. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893-962. 28. Andersson T, Magnuson A, Bryngelsson IL, Frobert O, Henriksson KM, EdvardssonN, et al. All-causemortality in 272,186 patients hospitalizedwith incident atrial fibrillation 1995-2008: a Swedish nationwide long-termcase control study. Eur Heart J. 2013;34(14):1061-7. 29. Monteiro P. Emnome dos Investigadores do Estudo Safira. The SAFIRA study: A reflection on the prevalence and treatment patterns of atrial fibrillation and cardiovascular risk factors in 7500 elderly subjects. Rev Port Cardiol. 2018;37(4):307-13. 30. Bonhorst D, Mendes M, Adragão P, De Sousa J, Primo J, Leiria E, et al. Prevalence of atrial fibrillation in the Portuguese population aged 40 and over: the FAMA study. Rev Port Cardiol. 2010;29(3):331-50. 31. Primo J, Gonçalves H, Macedo A, Russo P, Monteiro T, Guimarães J, et al. Prevalence of paroxysmal atrial fibrillation in a population assessed by continuous 24-hour monitoring. Rev Port Cardiol. 2017;36(7-8):535-46. 32. Freedman B, Camm J, Calkins H; AF-Screen Collaborators. Screening for atrial fibrillation: A report of the AF-SCREEN international collaboration. Circulation. 2017;135(19):1851-67. 33. Stephan LS, Almeida ED, Guimarães RB, Ley AG, Mathias RG, Assis MV, et al. Oral anticoagulation in atrial fibrillation: development and evaluation of a mobile health application to support shared decision-making. Arq Bras Cardiol. 2018;110(1):7-15. 34. Biro FM, WienM. Childhood obesity and adult morbidities. Am J ClinNutr. 2010;91(5):1499S-1505S. 35. Williams CL, Hayman LL, Daniels SR, Robinson TN, Steinberger J, Paridon S, et al.Cardiovascularhealth in childhood: astatement forhealthprofessionals from the committee on atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the council on cardiovascular disease in the young, American Heart Association. Circulation. 2002;106(1):143-60. 36. Peñalvo JL, Santos-Beneit G, Sotos-Prieto M, Bodega P, Oliva B, Orrit X, et al. The SI! Program for cardiovascular health promotion in early childhood: a cluster-randomized trial. J Am Coll Cardiol. 2015;66(14):1525–34. 37. Vedanthan R, Bansilal S, Soto AV, Kovacic JC, Latina J, JaslowR, et al. Family- based approaches to cardiovascular health promotion. J Am Coll Cardiol. 2016;67(14):1725-37. 38. Rodrigues PR, Pereira RA, Gama A, Carvalhal IM, Nogueira H, Rosado- Marques V, et al. Body adiposity is associatedwith risk of high blood pressure in Portuguese schoolchildren. Rev Port Cardiol. 2018;37(4):285-92. 39. Boelsen-Robinson T, Gearon E, Peeters A. Incidence of childhood obesity in the United States. N Engl J Med. 2014; 370(17):403-11. 40. Fuster V. Stratified approach to health: integration of science and education at the right time for each individual. J AmColl Cardiol. 2015;66(14):1627-9. 41. Safeer RS, Cooke CE, Keenan J. The impact of health literacy on cardiovascular disease. Vasc Health Risk Manag. 2006;2(4):457-64. 42. Andrade N, Alves E, Costa AR, Moura-Ferreira P, Azevedo A, Lunet N. Knowledge about cardiovascular disease in Portugal. Rev Port Cardiol. 2018;37(8):669-78. 43. PereiraH,PintoFJ, CaléR,PereiraE,Marques J,AlmeidaM,etal.Stent for life inPortugal:this initiative isheretostay.RevPortCardiol.2014;33(6):363-70. 44. Cardim N, Brito D, Rocha LL, Freitas A, Araújo C, Belo A, et al. The portuguese registry of hypertrophic cardiomyopathy: Overall results. Rev Port Cardiol. 2018;37(1):1-10. 45. Cecchi F, Olivotto I, Betocchi S, Rapezzi C, Conte MR, Sinagra G, et al. The Italian registry for hypertrophic cardiomyopathy: a nationwide survey. Am Heart J. 2005;150(5):947-54. 46. LipshultzSE,OravEJ,WilkinsonJD,TowbinJA,MessereJE,LoweAM.Pediatric CardiomyopathyRegistryStudyGroup.Riskstratificationatthetimeofdiagnosis for children with hypertrophic cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry Study Group. Lancet 2013;382(9908):1889-97. 47. FaxonDP, Burgess A. cardiovascular registries: Toomuch of good thing? Circ Cardiovasc Interv. 2016;9(4):e003866. 48. DelgadoV, Knuuti J, Plein S, Achenbach S, Bax JJ. The year in cardiology 2017: imaging. Eur Heart J. 2018;39(4):275-85. 49. Gripp EA, Oliveira GE, Feijó LA, Garcia MI, Xavier SS, Sousa AS. Global longitudinal strain accuracy for cardiotoxicity prediction in a cohort of breast cancer patients during anthracycline and/or trastuzumab treatment. ArqBras Cardiol. 2018;110(2):140-50. 50. Kappetein AP, Head SJ, Genereux P, PiazzaN, vanMieghemNM, Blackstone EH, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document. J Thorac Cardiovasc Surg. 2013;145(1):6-23. 51. Miyazaki Y, Modolo R, Abdelghani M, Tateishi H, Cavalcante R, Collet C, et al. Papel da avaliação aortográfica quantitativa da regurgitação aórtica por videodensitometria na orientação do implante da valva aórtica transcateter. Arq Bras Cardiol. 2018;111(2):193-202. 52. Martins CN, Gontijo Filho B, Lopes RM, Silva FD. Mid- and longterm neo- aortic valve regurgitation after jatene surgery: Prevalence and risk factors. Arq Bras Cardiol. 2018;111(1):21-8. 53. Moller JE, Hillis GS, Oh JK, Seward JB, Reeder GS, Wright RS, et al. Left atrial volume: A powerful predictor of survival after acute myocardial infarction. Circulation. 2003;107(17):2207-12. 54. Meris A, Amigoni M, Uno H, Thune JJ, Verma A, Køber L, et al. Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT echo study. Eur Heart J. 2009;30(1):56-65. 55. Wong RC, Yeo TC. Left atrial volume is an independent predictor of exercise capacity in patients with isolated left ventricular diastolic dysfunction. Int J Cardiol. 2010;144(3):425-7. 56. Fontes-Carvalho R, Sampaio F, Teixeira M, Ruivo C, Ribeiro J, Azevedo A, et al. Left atrial deformation analysis by speckle tracking echocardiography to predict exercise capacity after myocardial infarction. Rev Port Cardiol. 2018;37(10):821-30. 57. Blume GG, Mcleod CJ, Barnes ME, Seward JB, Pellikka PA, Bastiansen PM, et al. Left atrial function: physiology, assessment, and clinical implications. Eur J Echocardiogr. 2011;12(6):421-30. 58. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, et al. The seattle heart failure model: prediction of survival in heart failure. Circulation. 2006;113(11):1424-33. 59. O’Connor CM, Whellan DJ, Wojdyla D, Leifer E, Clare RM, Ellis SJ, et al. Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model. Circ Heart Fail. 2012;5(1):63-71. 60. Guazzi M, Bandera F, Ozemek C, Systrom D, Arena R. Cardiopulmonary exercise testing: what is its value? J AmColl Cardiol. 2017;70(13):1618-36. 61. Rodrigues JA,Prímola-GomesTN,SoaresLP,LealTF,NóbregaC,PedrosaDL, et al. Exercício físico e regulação de cálcio intracelular emcardiomiócitos de ratos hipertensos. Arq Bras Cardiol. 2018;111(2):172-9. 62. Silva DV, Waclawovsky G, Kramer AB, Stein C, Eibel B, Grezzana GB, et al. Comparison of cardiac and vascular parameters in powerlifters and long-distance runners: comparative cross-sectional study. Arq Bras Cardiol. 2018;111(6):772-81. 200